Results 181 to 190 of about 10,254 (215)

NEUROPATHIES OF MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE

Hematology/Oncology Clinics of North America, 1999
Although rare, MGUS neuropathies offer a unique glimpse of some the molecular mechanisms of autoimmunity. For this reason alone, they are important disorders and are being studied vigorously in many research centers around the world. In at least some cases, they are potentially treatable.
openaire   +2 more sources

[Monoclonal gammopathy of undetermined significance].

Annales de medecine interne, 2003
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic disorder with serum monoclonal immunoglobulin less than 30 g/l. It preferentially affects elderly patients; MGUS prevalence is about 1% in the general population and about 10% in patients aged over 80 years.
Pascal, Chaïbi, Laurence, Merlin, Caroline, Thomas, François, Piette   +3 more
openaire   +1 more source

Monoclonal Gammopathy of Undetermined Significance

New England Journal of Medicine
Majdolen, Istaiti, Ola, Landgren, Ari, Zimran   +2 more
openaire   +5 more sources

[Monoclonal gammopathies of undetermined significance].

La Revue de medecine interne, 2001
Monoclonal gammopathy of undetermined significance is an asymptomatic disorder associated with serum monoclonal immunoglobulin spike. Its incidence is about 1% in patients of 50 years of age, and rapidly increases in elderly patients.Within the 20 years following diagnosis, about 25% of patients will evolve towards either multiple myeloma (for patients
M, Zandecki, F, Geneviève, P, Jego, B, Grosbois   +3 more
openaire   +1 more source

Monoclonal Gammopathy of Undetermined Significance

Emerging Cancer Therapeutics, 2010
Sumit Madan, Vincent Rajkumar
openaire   +1 more source

Monoclonal gammopathy of undetermined significance.

Journal of insurance medicine (New York, N.Y.), 1997
Monoclonal gammopathy of undetermined significance is not a benign condition. There is a significant increase in mortality associated with the risk of development of multiple myeloma and related disorders.
openaire   +1 more source

Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition

Mayo Clinic Proceedings, 2012
Terry M Therneau, Robert A Kyle, Joanne T Benson   +2 more
exaly  

Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients

Mayo Clinic Proceedings, 2009
Robert A Kyle, Angela Dispenzieri, S Vincent Rajkumar   +2 more
exaly  

[Monoclonal gammopathies of undetermined significance].

Schweizerische medizinische Wochenschrift, 1983
In the majority of monoclonal gammopathies it is not possible to demonstrate an association with an underlying disease related to multiple myeloma, Waldenström's macroglobulinemia, malignant lymphoma or amyloidosis. After a lapse of months to years, however, some patients will develop one of the diseases mentioned.
openaire   +1 more source

Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana

Mayo Clinic Proceedings, 2007
Ola Landgren, Jerry A Katzmann, Edward D Yeboah   +2 more
exaly